Product Information
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.3107 per EA under NDC 62135046630. Its NADAC has been published 198 times since Sep 14, 2022.
Strength
300 mg/1
Manufacturer
Chartwell RX LLCNDC
62135046630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206481On Market Since
7/31/2018
Pharmacological Classes
Price Statistics
The NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has been published 198 times since Sep 14, 2022, and over the history we have for it it has declined 49.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3107 per EA |
|---|---|
| All-time high | $0.6141 (Sep 14, 2022) |
| All-time low | $0.3107 (Jun 17, 2026) |
| 52-week high | $0.4227 |
| 52-week low | $0.3107 |
| Median price | $0.4227 |
| Average price | $0.4314 |
| Largest weekly change | +40.8% (Aug 21, 2024) |
| Weeks tracked | 198 |
| Tracking since | Sep 14, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the TENOFOVIR DISOPROXIL FUMARATE Tablets market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, manufactured by Chartwell RX LLC, is $0.3107 per EA (NDC 62135046630), effective Jun 24, 2026.
How has the price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has declined 49.4%. It has been tracked across 198 weekly CMS publications since Sep 14, 2022.
What are the highest and lowest recorded NADAC prices for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
Since Sep 14, 2022, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has ranged from a low of $0.3107 (Jun 17, 2026) to a high of $0.6141 (Sep 14, 2022), with a median of $0.4227 per EA.
Are there cheaper alternatives to TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (NDC 62135046630) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification